When healthcare executives look at the potential for AI in their business, they see a conundrum.
One the one hand, the highly-regulated nature of healthcare makes it challenging because all content needs to be fully trustworthy, safe and approved by MLR. On the other hand, companies see the potential to transform the level of service that they can provide to HCPs and patients.
While it is a challenge, patterns and trends are already emerging. In a well-attended Anthill AI-focused webinar, we took the opportunity to survey the participants’ current plans. The results give a snapshot of where pharma is today and where it is heading.
Download the report to see how your peers are already responding to the AI opportunity.
